Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SToPClot: Sildenafil for CF Pump Thrombosis
NCT03199612Phase 1Completed
- Sponsor
- Montefiore Medical Center
- Start
- Jun 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ASP-001 in thrombosis (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Area Under the Curve for Adenosine Diphosphate at Day 15. Started Jun 2019; status: completed.
02
Drugs
ASP-001
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT03199612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03199612.